Literature DB >> 21964716

Translating evidence into policy in China: opportunities and challenges.

Jiyao Wang1, Xuejuan Jin.   

Abstract

Research and evidence are critical for the formulation of policies and practices in support of health care. In the past two decades, the Chinese Clinical Epidemiology Network has been promoting evidence-based policy making in China. Evidence-based policy has become a major part of the government's approach to policy making. The current article addresses the translation of evidence into health policies based on the expansion of evidence-based medicine in China. It also discusses the opportunities and challenges for certain evidence to be considered in policy making and practice in the future.

Mesh:

Year:  2011        PMID: 21964716     DOI: 10.1007/s11684-011-0146-6

Source DB:  PubMed          Journal:  Front Med        ISSN: 2095-0217            Impact factor:   4.592


  12 in total

1.  [Correct the misconceptions about evidence-base medicine].

Authors:  Ji-yao Wang
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2004-06-17

2.  [Guidelines for evidence-based Chinese medicine clinical pathway report].

Authors:  Si Cheng Wang; Jian-Ping Liu; Hui Li; He Yu
Journal:  Zhong Xi Yi Jie He Xue Bao       Date:  2010-09

3.  Reforming research in China.

Authors: 
Journal:  Lancet       Date:  2007-03-17       Impact factor: 79.321

Review 4.  Thinking and practice of accelerating transformation of traditional Chinese medicine from experience medicine to evidence-based medicine.

Authors:  Baoyan Liu; Yanhong Zhang; Jingqing Hu; Liyun He; Xuezhong Zhou
Journal:  Front Med       Date:  2011-06-22       Impact factor: 4.592

Review 5.  Consolidated standards of reporting trials (CONSORT) for traditional Chinese medicine: current situation and future development.

Authors:  Zhaoxiang Bian; Baoyan Liu; David Moher; Taixiang Wu; Youping Li; Hongcai Shang; Chungwah Cheng
Journal:  Front Med       Date:  2011-06-22       Impact factor: 4.592

6.  Evidence-based medicine in China.

Authors:  Jiyao Wang
Journal:  Lancet       Date:  2010-02-13       Impact factor: 79.321

7.  Lancet UK Policy Matters: better evidence for better health.

Authors:  Robert W Aldridge; Katie J Cole; Louise Hurst; Martin McKee; Richard Horton
Journal:  Lancet       Date:  2011-05-14       Impact factor: 79.321

8.  Translating evidence into policy in low-income countries: lessons from co-trimoxazole preventive therapy.

Authors:  Eleanor Hutchinson; Benson Droti; Diana Gibb; Nathaniel Chishinga; Susan Hoskins; Sam Phiri; Justin Parkhurst
Journal:  Bull World Health Organ       Date:  2011-02-28       Impact factor: 9.408

9.  Melamine-contaminated powdered formula and urolithiasis in young children.

Authors:  Na Guan; Qingfeng Fan; Jie Ding; Yiming Zhao; Jingqiao Lu; Yi Ai; Guobin Xu; Sainan Zhu; Chen Yao; Lina Jiang; Jing Miao; Han Zhang; Dan Zhao; Xiaoyu Liu; Yong Yao
Journal:  N Engl J Med       Date:  2009-02-04       Impact factor: 91.245

10.  Randomized trials published in some Chinese journals: how many are randomized?

Authors:  Taixiang Wu; Youping Li; Zhaoxiang Bian; Guanjian Liu; David Moher
Journal:  Trials       Date:  2009-07-02       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.